DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pyridostigmine bromideis the generic ingredient in three branded drugs marketed by Bausch, Sandoz Inc, Amneal Pharms Llc, Invatech, Novitium Pharma, Alvogen, Impax Labs Inc, Rising, Ani Pharms Inc, Elysium, Impax Labs, Solvay, Us Army, and Zydus Pharms, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.
There are eleven drug master file entries for pyridostigmine bromide. Eighteen suppliers are listed for this compound.
Recent Clinical Trials for pyridostigmine bromide
Identify potential brand extensions & 505(b)(2) entrants
|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||Phase 2/Phase 3|
|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||Phase 2|
|Vanderbilt University Medical Center||Phase 1|
Pharmacology for pyridostigmine bromide
|Drug Class||Cholinesterase Inhibitor |
|Mechanism of Action||Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for pyridostigmine bromide
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Ani Pharms Inc||PYRIDOSTIGMINE BROMIDE||pyridostigmine bromide||TABLET;ORAL||040512-002||Jul 20, 2005||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Elysium||PYRIDOSTIGMINE BROMIDE||pyridostigmine bromide||TABLET;ORAL||211181-001||Jul 20, 2018||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Rising||PYRIDOSTIGMINE BROMIDE||pyridostigmine bromide||TABLET, EXTENDED RELEASE;ORAL||205464-001||Aug 15, 2017||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Novitium Pharma||PYRIDOSTIGMINE BROMIDE||pyridostigmine bromide||SYRUP;ORAL||211694-001||Mar 8, 2019||AA||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.